Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 2/20 | 0.38 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.38 |
| ▸ | BLM | P54132 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | THPO | P40225 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.36 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.34 |
| ▸ | ENPEP | Q07075 | 8/20 | 0.34 |
| ▸ | ANPEP | P15144 | 3/20 | 0.34 |
| ▸ | ACE | P12821 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9636795 | 1.00 | PTGS1 (0.38) | PTGS1GSTK1MAPTPTGS2BLM | |
| SCHEMBL930369 | 0.87 | ACE (0.41) | PTGS1GSTK1MAPTPTGS2BLM | |
| SCHEMBL80875 | 0.82 | MAPT (0.50) | PTGS1GSTK1MAPTPTGS2BLM | |
| SCHEMBL69148 | 0.82 | MAPT (0.50) | PTGS1GSTK1MAPTPTGS2BLM | |
| SCHEMBL197221 | 0.82 | MAPT (0.50) | PTGS1GSTK1MAPTPTGS2BLM | |
| Ammonia Solution, Strong SCHEMBL19614515 | 0.80 | MAPT (0.48) | PTGS1GSTK1MAPTPTGS2BLM | |
| Ammonia Solution, Strong SCHEMBL19614510 | 0.80 | MAPT (0.48) | PTGS1GSTK1MAPTPTGS2BLM | |
| SCHEMBL16360193 | 0.79 | — | — | |
| SCHEMBL7574384 | 0.78 | MAPT (0.42) | PTGS1GSTK1MAPTPTGS2BLM | |
| SCHEMBL22361657 | 0.78 | MAPT (0.42) | PTGS1GSTK1MAPTPTGS2BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026087117-A1 | PERSONAL CARE COMPOSITION BASED ON CARBOXYMETHYL CYSTEINE COMPOUND AND ACETYL METHIONINE COMPOUND | UNILEVER IP HOLDINGS B.V. (NL) | 2026-04-30 | — | — | WO | claimed |
| WO-2025133279-A1 | HAIR CARE COMPOSITIONS | UNILEVER IP HOLDINGS B.V. (NL) | 2025-06-26 | — | — | WO | claimed |
| WO-2025133372-A1 | USE OF CYSTEINE PRECURSOR COMPOUND | UNILEVER IP HOLDINGS B.V. (NL) | 2025-06-26 | — | — | WO | claimed |
| WO-2025021553-A1 | A PERSONAL CARE COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2025-01-30 | — | — | WO | claimed |
| EP-4734942-A1 | A PERSONAL CARE COMPOSITION COMPRISING A CARBOXYMETHYL CYSTEINE COMPOUND AND AN EXTRACT OF ENGELHARDTIA GENUS | Unilever IP Holdings B.V. (NL) | 2026-05-06 | — | — | EP | disclosed |
| EP-4735119-A1 | A PERSONAL CARE COMPOSITION | Unilever IP Holdings B.V. (NL) | 2026-05-06 | — | — | EP | disclosed |
| EP-4734947-A1 | A PERSONAL CARE COMPOSITION | Unilever IP Holdings B.V. (NL) | 2026-05-06 | — | — | EP | disclosed |
| EP-4734934-A1 | PERSONAL CARE COMPOSITION BASED ON CARBOXYMETHYL CYSTEIN COMPOUND AND CAROTENOID OR ESTER THEREOF | Unilever IP Holdings B.V. (NL) | 2026-05-06 | — | — | EP | disclosed |
| EP-4734943-A1 | PERSONAL CARE COMPOSITION COMPRISING A CARBOXYMETHYL CYSTEINE COMPOUND AND A SILYMARIN COMPOUND | Unilever IP Holdings B.V. (NL) | 2026-05-06 | — | — | EP | disclosed |
| WO-2026087117-A1 | PERSONAL CARE COMPOSITION BASED ON CARBOXYMETHYL CYSTEINE COMPOUND AND ACETYL METHIONINE COMPOUND | UNILEVER IP HOLDINGS B.V. (NL) | 2026-04-30 | — | — | WO | disclosed |
| WO-2026041386-A1 | ANHYDROUS COMPOSITION COMPRISING MONOESTERS AND MAINLY PETROLATUM | UNILEVER IP HOLDINGS B.V. (NL) | 2026-02-26 | — | — | WO | disclosed |
| EP-4615403-A1 | PERSONAL CARE COMPOSITION | Unilever IP Holdings B.V. (NL) | 2025-09-17 | — | — | EP | disclosed |
| WO-2024099702-A1 | A PERSONAL CARE COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2024-05-16 | — | — | WO | disclosed |
| WO-2023126161-A1 | A PERSONAL CARE OR PHARMACEUTICAL COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2023-07-06 | — | — | WO | disclosed |
| WO-2023126238-A1 | PERSONAL CARE COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2023-07-06 | — | — | WO | disclosed |
| WO-2023126136-A1 | PERSONAL CARE COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2023-07-06 | — | — | WO | disclosed |
| WO-2023126169-A1 | USE OF CARBOXYMETHYL CYSTEINE COMPOUND | UNILEVER IP HOLDINGS B.V. (NL) | 2023-07-06 | — | — | WO | disclosed |
| EP-0272462-B1 | Process for preparing ursodeoxycholic acid derivates and their inorganic and organic salts having therpeutic activity. | Jago Research AG (CH) | 1992-06-10 | — | — | EP | disclosed |
| US-4865765-A | TREATMENT OF ALTERED BILIGENETIC FUNCTIONS AND LITHIASIS OR DYSKINESIA OF THE BILIARY DUCTS | JAGO RESEARCH AG (CH) | 1989-09-12 | — | — | US | disclosed |
| EP-0272462-A1 | Process for preparing ursodeoxycholic acid derivates and their inorganic and organic salts having therpeutic activity. | Jago Research AG (CH) | 1988-06-29 | — | — | EP | disclosed |